Invest in

Sell in May?


Time To Play Defense

‘Sell in May and go away’ is a well-known stock market adage that suggests investors should move to cash as April ends – and stay there until November, when the market has historically been perceived to be ready to begin a six-month stretch of seasonal outperformance. Utilizing the idea of rotating into defensive stocks has shown to be an attractive alternative in the past. A study on the sector-rotation process demonstrated that a portfolio that invested in defensive sectors from May through October, and in cyclical, growth-oriented stocks from November to April beat the S&P 500 by an average of 8.5% over the past 20 years. Even better – overweighting in traditionally stable sectors like healthcare and consumer staples gave the defensive portfolio a boost with those two stock groups posting average returns of 4.8% and 5%, respectively between May and October while the S&P 500 gained just 1.4% over the same 20-year-period.[1] This motif uses a sector-rotation approach to maintain equity exposure all year long while seeking to reduce risk during the traditionally volatile summer months. See more
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Sell in May? Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
50.3% Consumer Staples 7.0%
7.9% Wal-Mart Stores Inc. WMT 12.4%
6.0% Procter & Gamble Company (The) PG 14.0%
5.5% Coca-Cola Company (The) KO 2.0%
5.4% Pepsico Inc. PEP 15.8%
5.2% Sysco Corporation SYY 18.0%
4.4% Colgate-Palmolive Company CL 8.4%
3.9% CVS Health Corporation CVS 19.8%
3.5% General Mills Inc. GIS 0.8%
3.0% Kellogg Company K 0.3%
2.5% Campbell Soup Company CPB 1.6%
1.6% Kimberly-Clark Corporation KMB 2.6%
1.4% Dr. Pepper Snapple Group Inc. DPS 16.2%
49.7% Health Care 9.1%
9.1% UnitedHealth Group Incorporated (DE) UNH 31.2%
5.8% Johnson & Johnson JNJ 10.3%
5.4% Eli Lilly and Company LLY 8.7%
4.7% Abbott Laboratories ABT 2.8%
4.5% Stryker Corporation SYK 23.1%
4.4% Pfizer Inc. PFE 5.4%
3.4% McKesson Corporation MCK 22.1%
3.2% Medtronic plc. MDT 5.4%
2.9% Cardinal Health Inc. CAH 13.6%
2.1% DaVita Inc. DVA 8.1%
2.1% Henry Schein Inc. HSIC 0.4%
1.3% Baxter International Inc. BAX 24.4%
0.9% Zimmer Biomet Holdings Inc ZBH 7.4%

Quotes delayed 15 mins. Currently Apr 24, 2017 9:12:42 AM. Fields are marked with -- when data is unavailable.